Hjem › Blodsygdomme › North Carolina
Blodsygdomme kliniske forsøg i North Carolina
9 studier for Blodsygdomme søger deltagere på steder i North Carolina.
Byer i North Carolina
Officiel studietekst (engelsk)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- East Carolina University, Greenville
- Wake Forest University Baptist Medical Center, Winston-Salem
RekruttererFase 3
Alder 12 til 100 · Alle køn · Opdateret 28. sep. 2026 · NCT06439082Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 27, Chapel Hill
RekruttererFase 3
Alder 18 til 71 · Alle køn · Opdateret 23. sep. 2026 · NCT07504458A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Duke University Hospital, Durham
- East Carolina University, Greenville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT06722235A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
- East Carolina University, Greenville
RekruttererFase 3
Alder 18 til 70 · Alle køn · Opdateret 11. sep. 2026 · NCT07059000A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Duke University Hospital, Durham
- East Carolina University, Greenville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT06948318ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Comprehensive Hemophilia Treatment Center, University of North Carolina at Chapel Hill, Chapel Hill
- St. Jude Affiliate Clinic at Novant Health Hemby Children's Hospital, Charlotte
- East Carolina University Hemophilia Treatment Center, Greenville
- og 1 flere
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 17. aug. 2026 · NCT04398628A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Duke University, Durham
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 30. apr. 2026 · NCT04256317ATHNdataset Registry
- American Thrombosis and Hemostasis Network, Hickory
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 21. apr. 2026 · NCT06820515Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
- Levine Children's Hospital - Hematology, Charlotte
RekruttererFase 3
Alder 12 til 35 · Alle køn · Opdateret 23. mar. 2026 · NCT05477563Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.